Skip to content

Endoscopic submucosal dissection for gastric stromal tumors less than 2 cm: a prospective, open-label, controlled clinical trial

Endoscopic submucosal dissection for gastric stromal tumors less than 2 cm: a prospective, open-label, controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONN-17012296
Enrollment
Unknown
Registered
2017-08-08
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric stromal tumor

Interventions

treatment group of ESD:ESD
treatment group of EMSLD:EMSLD
control group:endoscopy follow-up

Sponsors

Nanfang Hospital, Southern Medical University.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Definite diagnosis of gastric stromal tumor based on gastroscopy, endoscopic ultrasonography and pathology; 2) Gastric stromal tumor less than 20 mm in size, without high-risk EUS features; 3) Chinese patients aged from 18 to 70 years old, signing informed consent form and orally informed of clinical trial protocol.

Exclusion criteria

Exclusion criteria: 1) Gastric stromal tumor involving serosal layer or obviously convex to outside cavity; 2) Gastric stromal tumor with remote metastasis; 3) Serious accompanied diseases such as severe cardiovascular and cerebrovascular diseases.

Design outcomes

Primary

MeasureTime frame
progression-free survival;

Secondary

MeasureTime frame
success rate of operation;

Countries

China

Contacts

Public ContactLi Yue

Nanfang Hospital, Southern Medical University

liyue_1989919@126.com+86 15975537291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026